Cerebral amyloid angiopathy (CAA) is a condition in which a protein called amyloid builds up in the walls of small and medium blood vessels in the brain's outer layer, weakening them until they leak or rupture. For a caregiver, that matters because CAA raises the risk of brain bleeding and can cause or worsen the memory and thinking problems seen in dementia, so daily care has to account for both conditions at once. CAA is strongly age-related, with most cases appearing after age 55, and it becomes far more common the longer someone lives, according to NIH's MedlinePlus. It also overlaps heavily with dementia: a systematic review of autopsy studies found CAA of any severity in 55–59% of people who had dementia, compared with 28–38% of those who did not, according to a PMC systematic review.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What Is Cerebral Amyloid Angiopathy, and How Is It Connected to Dementia?
- Recognizing the Warning Signs at Home
- How Doctors Diagnose CAA — and Why a Diagnosis Can Stay Uncertain
- Why There's No Cure, and What Treatment Actually Targets
- The Blood-Thinner Dilemma and Fall Risk
- Frequently Asked Questions
What Is Cerebral Amyloid Angiopathy, and How Is It Connected to Dementia?
CAA develops when amyloid protein accumulates in the walls of blood vessels in the brain's cortex, the outer layer responsible for memory, language, and reasoning. Over time this buildup makes vessel walls fragile, which can lead to small or large bleeds in that region, according to MedlinePlus. The link to dementia is well established in large studies.
In the Adult Changes in Thought autopsy cohort of 848 people, with an average age at death of 86.7, CAA was found in 38.0% of brains examined, and dementia was significantly more common in those with CAA than those without (53.7% versus 40.1%), according to the Neurology-published ACT autopsy cohort study. Severity matters too: the same systematic review found severe CAA in 37–43% of people with dementia, versus just 7–24% of people without it, according to the PMC systematic review. This does not mean CAA causes every case of dementia it appears alongside, or that every person with CAA will develop dementia. It means the two conditions frequently coexist in older adults, and a caregiver supporting someone with memory loss should know that unexplained confusion, headaches, or sudden neurological changes could have a vascular cause layered on top of a dementia diagnosis.
Recognizing the Warning Signs at Home
CAA's hallmark is bleeding concentrated in the brain's outer cortex rather than its deep structures, and the symptoms depend on the size of the bleed. A large bleed tends to produce stroke-like symptoms: sudden drowsiness, severe headache, confusion, or seizures, according to MedlinePlus. These require emergency care the same way a stroke does.
Smaller bleeds are easier to miss because they can look like ordinary aging or a dementia flare-up. They may cause brief episodes of confusion, headaches that keep recurring, or a gradual decline in memory that mimics worsening dementia rather than announcing itself as a vascular event, per the same MedlinePlus source. For a caregiver tracking day-to-day behavior, this means: Keeping a simple daily log of alertness, headaches, and any confusion episodes gives clinicians a clearer picture than relying on memory of "how things have been.".
- A sudden, sharp change in alertness or speech is urgent — treat it like a possible stroke and seek emergency evaluation.
- Recurring headaches with no clear cause are worth reporting to the person's doctor, even if they resolve on their own.
- A new dip in memory or attention that is sharper than the person's usual pattern deserves a medical check rather than being attributed automatically to the underlying dementia.
How Doctors Diagnose CAA — and Why a Diagnosis Can Stay Uncertain
Since 2010, clinicians have used the Boston criteria, an MRI-based framework that classifies CAA as definite, probable, or possible based on the pattern of bleeding in the outer brain (lobar hemorrhage), the person's age (over 55), and ruling out other causes, according to a study hosted by TU Dresden. Adding microbleed detection on MRI meaningfully improves accuracy — in one study of Dutch-type CAA, sensitivity for identifying probable CAA rose from 48% to 63% once microbleeds were factored in. Even with modern imaging, a fully confirmed CAA diagnosis generally still requires examining brain tissue under a microscope, which usually only happens through a brain biopsy or an autopsy.
Physical exams and even brain scans can look normal when bleeds are small, so many living patients are told they have "probable" CAA rather than a confirmed diagnosis, according to MedlinePlus. For a caregiver, this means a "probable CAA" label on a loved one's chart is not a lesser or tentative concern — it reflects the real limits of what imaging alone can show while someone is alive. It is still the basis doctors use to guide monitoring and treatment decisions.
Why There's No Cure, and What Treatment Actually Targets
No treatment currently reverses or stops CAA itself. A 2025 narrative review describes care as symptom- and complication-focused rather than disease-modifying, according to a PMC narrative review.
The same review notes that people with CAA are often excluded from newer anti-amyloid Alzheimer's drugs, because those medications carry an elevated risk of brain bleeding and swelling in people whose vessels are already weakened by amyloid. When a bleed does occur, management centers on strict blood pressure control and reducing further bleeding risk, since CAA-related hemorrhages recur more often than bleeds caused by high blood pressure alone — one review cites a recurrence rate of roughly 21% — according to a Frontiers in Neurology systematic review. This is a long-term management posture, not a one-time fix, which is relevant for a caregiver planning ongoing medical follow-up rather than expecting a single treatment to resolve the risk.
The Blood-Thinner Dilemma and Fall Risk
Many older adults with CAA also have conditions like atrial fibrillation that call for blood thinners to prevent clot-related strokes. But those same medications raise the risk of CAA-related bleeding, and oral anticoagulation has been linked to more microbleeds on brain imaging in people with CAA, according to a clinical review published by The Hospitalist. This is a genuine medical trade-off without a universal answer, which is why the decision belongs to the prescribing physician rather than being adjusted by a caregiver independently.
A published case report illustrates how these risks compound in real caregiving situations: a 93-year-old woman with dementia and CAA, taking apixaban for a prior blood clot, experienced a brain hemorrhage and then a hip fracture from a fall, according to a case report in PMC. For a caregiver, the practical takeaway is that fall prevention is not a separate task from managing CAA — it is directly tied to it, especially when the person is on blood thinners. That means:.
- Removing loose rugs, improving lighting, and installing grab bars reduces the odds that a minor stumble becomes a major bleed-related injury.
- Any fall, even one that seems minor, should be reported to the person's doctor given the combined stroke and fracture risk shown in the case above.
- Medication reviews with the prescribing physician should explicitly weigh clot risk against bleeding risk, since both carry serious consequences for someone with CAA.
Frequently Asked Questions
Can a brain scan rule out CAA completely?
Not reliably. Imaging can appear normal even when small bleeds are present, so a fully confirmed diagnosis generally requires examining brain tissue, usually through biopsy or autopsy, according to MedlinePlus.
Does having CAA mean someone will definitely develop dementia?
No. CAA and dementia overlap heavily in older adults, but autopsy data shows many people without dementia also have CAA, and severity varies widely between individuals, according to the PMC systematic review.
Is any medication available to treat CAA directly?
No disease-modifying treatment exists; care focuses on managing symptoms and complications like bleeding, according to the 2025 PMC narrative review.
